
    
      To confirm a non-inferior effect and the safety of the investigated antimicrobial fosfomycin
      regimen in PJI of the hip, knee or shoulder against an assumed 80% effect (PJI-free
      proportion within one year for standard antibiotics aside fosfomycin), following a
      standardized surgical therapy involving retention, one-stage exchange or two-stage exchange
      (with short or long interval).
    
  